ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They?

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are antihypertensive agents that can be considered for migraine preventative therapy. Although the exact mechanisms by which ACE inhibitors and ARBs may work for migraine prophylaxis are unknown, there are several plausible hypotheses as to why modulating the activity of the renin angiotensin system could result in migraine prevention. Clinical trials of ACE inhibitors and ARBs provide evidence that they are effective and generally well tolerated when used for migraine prophylaxis. Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, we consider ACE inhibitors and ARBs as second- or third-line options for migraine prophylaxis.

Original languageEnglish (US)
Article number15
Pages (from-to)1-9
Number of pages9
JournalCurrent Treatment Options in Neurology
Volume18
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Angiotensin Receptor Antagonists
Peptidyl-Dipeptidase A
Migraine Disorders
Angiotensin-Converting Enzyme Inhibitors
Clinical Trials
Therapeutics
Renin-Angiotensin System
Antihypertensive Agents
Guidelines

Keywords

  • Angiotensin converting enzyme inhibitors
  • Angiotensin receptor blockers
  • Headache
  • Migraine

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They? / Halker Singh, Rashmi B; Starling, Amaal; Vargas, Bert B.; Schwedt, Todd J.

In: Current Treatment Options in Neurology, Vol. 18, No. 4, 15, 01.04.2016, p. 1-9.

Research output: Contribution to journalArticle

@article{c23b2daa833b48e4a9c4db41add6b288,
title = "ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They?",
abstract = "Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are antihypertensive agents that can be considered for migraine preventative therapy. Although the exact mechanisms by which ACE inhibitors and ARBs may work for migraine prophylaxis are unknown, there are several plausible hypotheses as to why modulating the activity of the renin angiotensin system could result in migraine prevention. Clinical trials of ACE inhibitors and ARBs provide evidence that they are effective and generally well tolerated when used for migraine prophylaxis. Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, we consider ACE inhibitors and ARBs as second- or third-line options for migraine prophylaxis.",
keywords = "Angiotensin converting enzyme inhibitors, Angiotensin receptor blockers, Headache, Migraine",
author = "{Halker Singh}, {Rashmi B} and Amaal Starling and Vargas, {Bert B.} and Schwedt, {Todd J}",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s11940-016-0397-2",
language = "English (US)",
volume = "18",
pages = "1--9",
journal = "Current Treatment Options in Neurology",
issn = "1092-8480",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They?

AU - Halker Singh, Rashmi B

AU - Starling, Amaal

AU - Vargas, Bert B.

AU - Schwedt, Todd J

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are antihypertensive agents that can be considered for migraine preventative therapy. Although the exact mechanisms by which ACE inhibitors and ARBs may work for migraine prophylaxis are unknown, there are several plausible hypotheses as to why modulating the activity of the renin angiotensin system could result in migraine prevention. Clinical trials of ACE inhibitors and ARBs provide evidence that they are effective and generally well tolerated when used for migraine prophylaxis. Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, we consider ACE inhibitors and ARBs as second- or third-line options for migraine prophylaxis.

AB - Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are antihypertensive agents that can be considered for migraine preventative therapy. Although the exact mechanisms by which ACE inhibitors and ARBs may work for migraine prophylaxis are unknown, there are several plausible hypotheses as to why modulating the activity of the renin angiotensin system could result in migraine prevention. Clinical trials of ACE inhibitors and ARBs provide evidence that they are effective and generally well tolerated when used for migraine prophylaxis. Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, we consider ACE inhibitors and ARBs as second- or third-line options for migraine prophylaxis.

KW - Angiotensin converting enzyme inhibitors

KW - Angiotensin receptor blockers

KW - Headache

KW - Migraine

UR - http://www.scopus.com/inward/record.url?scp=84959365481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959365481&partnerID=8YFLogxK

U2 - 10.1007/s11940-016-0397-2

DO - 10.1007/s11940-016-0397-2

M3 - Article

AN - SCOPUS:84959365481

VL - 18

SP - 1

EP - 9

JO - Current Treatment Options in Neurology

JF - Current Treatment Options in Neurology

SN - 1092-8480

IS - 4

M1 - 15

ER -